Alnababteh Muhtadi H, Huang Sean Shenghsiu, Ryan Andrea, McGowan Kevin M, Yohannes Seife
Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC.
Department of Health Systems Administration, Georgetown University, Washington, DC.
Crit Care Explor. 2020 Nov 24;2(12):e0251. doi: 10.1097/CCE.0000000000000251. eCollection 2020 Dec.
To evaluate if a hospitalwide sepsis performance improvement initiative improves compliance with the Centers for Medicare and Medicaid Services-mandated sepsis bundle interventions and patient outcomes.
Retrospective analysis comparing 6 months before and 14 months after intervention.
Tertiary teaching hospital in Washington, DC.
Patients admitted with a diagnosis of sepsis to a tertiary hospital.
Implementation of a multimodal quality-improvement initiative.
A total of 4,102 patients were diagnosed with sepsis, severe sepsis, or septic shock during the study period, 861 patients (21%) were diagnosed during a 6-month preintervention period, and 3,241 (79%) were diagnosed in a 13-month postintervention period. Adjusted for patient case-mix, the prevalence of simple sepsis increased by 12%, but it decreased for severe sepsis and septic shock by 5.3% and 6.9%, respectively. Compliance with all sepsis bundle interventions increased by 31.1 percentage points ( < 0.01). All-cause hospital readmission and readmission due to infection were both reduced by 1.6% and 1.7 percentage points ( < 0.05). Death from any sepsis diagnosis was reduced 4.5% ( < 0.01). Death from severe sepsis and septic shock both was reduced by 5% ( < 0.01) and 6.5% ( < 0.01), respectively.
After the implementation of multimodal sepsis performance initiatives, we observed a higher prevalence of sepsis secondary to screening but a lower prevalence of severe sepsis and septic shock, an improvement in compliance with the sepsis bundle interventions bundle, as well as reduction in hospital readmission and all- cause mortality rate.
评估一项全院性脓毒症绩效改进计划是否能提高对医疗保险和医疗补助服务中心规定的脓毒症集束化干预措施的依从性以及改善患者预后。
对干预前6个月和干预后14个月进行回顾性分析。
华盛顿特区的一家三级教学医院。
诊断为脓毒症并入住三级医院的患者。
实施多模式质量改进计划。
在研究期间,共有4102例患者被诊断为脓毒症、严重脓毒症或脓毒性休克,其中861例患者(21%)在干预前6个月被诊断,3241例患者(79%)在干预后13个月被诊断。经患者病例组合调整后,单纯脓毒症的患病率增加了12%,但严重脓毒症和脓毒性休克的患病率分别下降了5.3%和6.9%。对所有脓毒症集束化干预措施的依从性提高了31.1个百分点(P<0.01)。全因住院再入院率和感染导致的再入院率分别降低了1.6%和1.7个百分点(P<0.05)。任何脓毒症诊断导致的死亡率降低了4.5%(P<0.01)。严重脓毒症和脓毒性休克导致的死亡率分别降低了5%(P<0.01)和6.5%(P<0.01)。
在实施多模式脓毒症绩效改进计划后,我们观察到筛查导致的脓毒症患病率较高,但严重脓毒症和脓毒性休克的患病率较低,对脓毒症集束化干预措施的依从性有所改善,同时住院再入院率和全因死亡率降低。